STRATEGIC INCOME OPPORTUNITIES FUND CLASS R6 (JIPRX US) stock market data APIs
10.0821
0(0%)
as of July 14, 2025
Try our APIs with
free plan!
STRATEGIC INCOME OPPORTUNITIES FUND CLASS R6 Financial Data Overview
Price chart is built with
Anychart
Prev. Close
10.0821
Open
10.0821
High
10.0821
Low
10.0821
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get STRATEGIC INCOME OPPORTUNITIES FUND CLASS R6 data using free add-ons & libraries
End-of-day & Earnings data
Get STRATEGIC INCOME OPPORTUNITIES FUND CLASS R6 Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get STRATEGIC INCOME OPPORTUNITIES FUND CLASS R6 End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
STRATEGIC INCOME OPPORTUNITIES FUND CLASS R6 News
New
Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants
LUND, Sweden, Jan. 19, 2021 /PRNewswire/ -- Immunovia AB, ("Immunovia") announces today that Patrik Dahlen, CEO of Immunovia, has purchased 250,000 warrants of the 2020/2024 scheme for approximately 4...
Immunovia to Host a Third Webinar in the Series on IMMray™ PanCan-d: Verification Study and Clinical Use
LUND, Sweden, Dec. 11, 2020 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia"), a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray technology pla...
Nomination Committee appointed for the 2021 Annual General Meeting of Immunovia AB (Publ)
According to the instructions for the Nomination Committee of Immunovia AB (Publ) that were adopted at the Annual General Meeting on May 7, 2020, the Nomination Committee shall consist of four members...
Immunovia Provides Complementary Details on the IMMray™ PanCan-d Verification Study
LUND, Sweden, Nov. 2, 2020 /PRNewswire/ -- Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced further ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
